Shigeo Fuji

53PUBLICATIONS
78CO-AUTHORS
HaematologyHaematological tumoursProsthetics and orthoticsTransplantation immunologyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jul 14, 2026
Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma.

|Jun 17, 2026
WT1 peptide vaccines of post-allogeneic HSCT maintenance immunotherapy for pediatric acute leukemias: a phase II study.

|Jun 16, 2026
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experience.

|Mar 23, 2026
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantation.

Shigeo Fuji, Akihiro Ohmoto, Yuho Najima

|Feb 19, 2026
Targeted screening for HTLV-1 infection in endemic and non-endemic regions: a global public health priority.

Shigeo Fuji, Tatiane Assone, Jorge Casseb

|Feb 18, 2026
Health state utilities for relapsed or refractory large B-cell lymphoma treatments: a time trade-off study in the Japanese general population.

Shigeo Fuji, Hiroshi Ando, Kana Takaura

Pageof 9

Frequent Collaborators

12 joint publications

Yoshiko Atsuta

7 joint publications

Naoyuki Uchida

6 joint publications

Yoshinobu Kanda

6 joint publications

Makoto Onizuka